Artificial Intelligence-Powered Sugar.IQ Diabetes Management App Developed by Medtronic and IBM Watson Health Now Commercially Available
Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, and its strategic technology partner, IBM (NYSE:IBM) Watson Health, today announced commercial availability of the Sugar.IQ smart diabetes assistant, a first-of-its-kind intelligent app designed to simplify and improve daily diabetes management.
#product & service
#mobile app